Shionogi says COVID pill trial shows reduction in symptoms




  • In Health
  • 2022-09-28 03:02:40Z
  • By Reuters
 

TOKYO (Reuters) -Japan's Shionogi & Co Ltd said on Wednesday its oral treatment for COVID-19 demonstrated a significant reduction in symptoms compared with a placebo in a Phase III trial in Asia.

The drug, a protease inhibitor known as ensitrelvir, met its primary endpoint in a trial conducted among predominantly vaccinated patients with mild to moderate cases of COVID-19, the company said in a statement.

Shionogi's shares reversed an early decline after the announcement, closing 1.1% higher in Tokyo versus a 1.5 drop in the benchmark Nikkei gauge.

Ensitrelvir met the trial's goal in reducing five key symptoms of the Omicron variant of COVID-19 within 72 hours of onset, the company said.

Regulatory authorities in Japan previously denied emergency approval for use of the pill, saying they wanted to see more data on its effectiveness. There are also concerns the drug could pose risk to pregnancies, based on results from animal studies.

Shionogi said it has shared top-line data from the Phase III study with Japanese regulators as part of deliberations on approval of the drug.

Shionogi has global aspirations for the drug, also known as S-217622 and by the brand name Xocova, which would compete with COVID-19 pills from Pfizer Inc and Merck & Co Inc that have already been approved in Japan and elsewhere.

The company has signed an agreement to sell about a million doses to the government, pending the drug's approval.

Chief Executive Isao Teshirogi has said annual production of the drug could reach 10 million doses. The firm has received U.S. government support for a global Phase III trial.

(Reporting by Rocky Swift; Editing by Christopher Cushing, Richard Pullin and Angus MacSwan)

COMMENTS

More Related News

When the chips go up: Big banks bet on South Korea, Taiwan stocks for 2023
When the chips go up: Big banks bet on South Korea, Taiwan stocks for 2023

Global banks are turning bullish on South Korean and Taiwanese shares, expecting a revival in semiconductors to drive a rally next year, while they see...

The Disney Store in Japan is selling a shirt that shows Winnie the Pooh holding up a white sheet of paper - the same protest symbol sweeping across China
The Disney Store in Japan is selling a shirt that shows Winnie the Pooh holding up a white sheet of paper - the same protest symbol sweeping across China
  • World
  • 2022-12-01 09:02:07Z

Chinese citizens have likened Winnie the Pooh to Chinese President Xi Jinping, while the blank paper Pooh holds is a symbol of China protests.

Binance Re-Enters Japan With Sakura Exchange Purchase
Binance Re-Enters Japan With Sakura Exchange Purchase

(Bloomberg) -- Binance, the world's biggest cryptocurrency exchange, bought a Japan crypto exchange service provider to re-enter a market it said will play a...

Covid Arbitrage Trade Dries Up in Japan and Overnight Rates Drop
Covid Arbitrage Trade Dries Up in Japan and Overnight Rates Drop

(Bloomberg) -- Overnight yen borrowing costs have fallen to the lowest in more than six years, as a profitable arbitrage opportunity for Japanese lenders...

Asian shares rise except Japan as markets eye China protests
Asian shares rise except Japan as markets eye China protests
  • US
  • 2022-11-29 05:44:09Z

Asian shares were mostly higher Tuesday as jitters over protests in China set off by growing public anger over COVID-19 restrictions subsided. Oil prices...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Health